Table 1.
Exclusion criteria for comparison of GRT versus GRT + rPRT
| All N (%) |
GRT N (%) |
GRT + rPRT N (%) |
|
|---|---|---|---|
| Ineligible tests - n (% of total tests) | 1459 | 1120 | 339 |
| No change of ART after RT | 708 (49.0) | 532 (47.5) | 176 (51.9) |
| Change of ART only >1 year after last RT | 526 (36.1) | 411 (36.7) | 116 (34.2) |
| Off treatment for >6 months after RT | 126 (8.6) | 105(9.4) | 21 (6.2) |
| No RNA during study period* | 98 (6.7) | 74 (6.6) | 25 (7.4) |
| Other# | 1 (0.01) | 0.0 | 1 (0.3) |
* The study period is the time from the 1st change of ART after RT until the earliest of either changing ART due to failure (RNA >400), going off treatment, or December 31, 2008.
# Participation in a structured treatment interruption trial.
RT = resistance test, GRT = genotype RT, rPRT = replicative phenotype RT, cART = combined antiretroviral therapy